Soonchunhyang Med Sci.  2018 Jun;24(1):55-58. 10.0000/sms.2018.24.1.55.

Clinical Manifestations, Gene Analysis of Patients with 3-Methylcrotonyl-CoA Carboxylase Deficiency

Affiliations
  • 1Department of Pediatrics, Soonchunhyang University Seoul Hospital, Seoul, Korea. yamim@daum.net
  • 2Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

Abstract


OBJECTIVE
3-Methylcrotonyl CoA carboxylase deficiency (3MCCD) is classified as organic acid disease due to leucine catabolism. It is among the most common inborn errors of metabolism identified on newborn screening test using tandem mass spectrometry. There is a broad spectrum of clinical presentations. 3-Methylcrotonyl CoA carboxylase converts 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA using biotin as a coenzyme in mitochondria. Restricting protein diets and supplementing carnitine, glycine, and biotin are known treatments. We reported this study to find out clinical symptoms, type of gene mutation, and effect of treatment.
METHODS
This study was based on retrospective data of patients with 3MCCD in Soonchunhyang University Seoul Hospital and Soonchunhyang University Bucheon Hospital between April 2009 to August 2016.
RESULTS
All 10 infants were born term infants and had no symptoms. During the neonatal period, abnormalities were detected in the new born screening test using tandem mass spectrometry, 3-hydroxyisovalerylcarnitine was increased. 3-Methylcrotonylglycine (3MCG) and 3-hydroxyisovalreric acid (3HIVA) were examined in urine organic acid assay. The results showed that 3MCG was increased in all 10 children. Except for three of the 10 children, 3HIVA was increased. Genetic tests were performed on all 10 children. MCCC1 gene mutations were detected in four patients and MCCC2 mutations were detected in six patients. After diagnosis, all children were recommended leucine-restricted diets, and seven of the 10 patients started to feed on leucine free formula for the treatment of 3MCCD.
CONCLUSION
According to our data, all patients has no symptoms and are shown normal development. There were no clinical symptoms or changes in prognosis according to gene mutation type.

Keyword

3-Methylcrotonyl-CoA carboxylase deficiency; Neonatal screening; Retrospective studies

MeSH Terms

Biotin
Carnitine
Child
Diagnosis
Diet
Glycine
Gyeonggi-do
Humans
Infant
Infant, Newborn
Leucine
Mass Screening
Metabolism
Metabolism, Inborn Errors
Mitochondria
Neonatal Screening
Prognosis
Retrospective Studies
Seoul
Tandem Mass Spectrometry
Biotin
Carnitine
Glycine
Leucine
Full Text Links
  • SMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error